October 25, 2011 — Stentys S.A. announced the publication of the results of the APPOSITION I clinical study in the September issue of the medical journal EuroIntervention.
The study showed the Stentys Self-Apposing Stent enabled the perfect apposition of these stents when treating patients with acute myocardial infarction (AMI). The self-apposing feature ensures optimal apposition during thrombus and vessel spasm relief in the critical initial hours and days after an AMI procedure; this avoids malapposition, a significant concern to cardiologists.
“We continue to be very pleased with the results of the Stentys Self-Apposing Stent when treating AMI,” said Giovanni Amoroso, M.D., OLVG Hospital (Amsterdam, the Netherlands) and lead author of the article. “During the six-month follow-up period of the APPOSITION I study, there was no death, no stent thrombosis or reoccurrence of MI, with revascularization rates comparable to that of conventional stents.”
EuroIntervention is the official publication of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI); it is endorsed by the European Society of Cardiology (ESC).
For more information: www.eurointervention.org